Robert Wong Cytokinetics Inc (CYTK) insider trading activity

Robert Wong is VP, Chief Accounting Officer of CYTOKINETICS INC. Currently has a direct ownership of 16,653 shares of CYTK, which is worth approximately $830,318. The most recent transaction as insider was on Jun 03, 2024, when has been sold 13,011 shares (Common Stock) at a price of $48.88 per share, resulting in proceeds of $635,977. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.7K

0% 3M change

22.95% 12M change

Total Value Held $830,318

Robert Wong Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2024	SELL Open market or private sale	$635,977 $48.88 p/Share	13,011 Reduced 43.86%	16,653 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	4,079 Added 12.09%	29,664 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$57,316 $66.88 p/Share	857 Reduced 3.24%	25,585 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$120,673 $67.68 p/Share	1,783 Reduced 6.32%	26,442 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$27,077 $39.13 p/Share	692 Reduced 3.1%	21,613 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	6,000 Added 17.85%	27,613 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$98,366 $39.6 p/Share	2,484 Reduced 10.02%	22,305 Common Stock
Feb 21 2023	SELL Open market or private sale	$100,999 $45.21 p/Share	2,234 Reduced 8.27%	24,789 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$22,506 $44.13 p/Share	510 Reduced 1.85%	27,023 Common Stock
Feb 03 2023	SELL Open market or private sale	$135,180 $45.0 p/Share	3,004 Reduced 9.84%	27,533 Common Stock
Nov 14 2022	SELL Open market or private sale	$85,428 $40.68 p/Share	2,100 Reduced 6.43%	30,537 Common Stock
Mar 07 2022	SELL Payment of exercise price or tax liability	$50,973 $36.83 p/Share	1,384 Reduced 4.15%	31,960 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$54,451 $37.63 p/Share	1,447 Reduced 5.3%	25,844 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	7,500 Added 18.36%	33,344 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	1,987 Added 6.79%	27,291 Common Stock
Mar 08 2021	SELL Payment of exercise price or tax liability	$26,079 $19.19 p/Share	1,359 Reduced 5.38%	23,879 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	10,000 Added 28.38%	25,238 Common Stock

Robert Wong

VP, Chief Accounting Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account